22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
Industry, Sector and Symbol
Stock Exchange NYSEAMERICAN
Industry Biotechnology
Sub-IndustryCannabis
SectorMedical
Current SymbolNYSEAMERICAN:XXII
Previous SymbolAMEX:XXII
CUSIPN/A
Phone+1-716-2701523
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees79
Outstanding Shares124,400,000
Market Cap$0.00
OptionableOptionable
22nd Century Group (NYSEAMERICAN:XXII) Frequently Asked Questions
What is 22nd Century Group's stock symbol?
22nd Century Group trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XXII."
How were 22nd Century Group's earnings last quarter?
22nd Century Group Inc (NYSEAMERICAN:XXII) issued its quarterly earnings results on Wednesday, November, 7th. The biotechnology company reported $0.04 earnings per share (EPS) for the quarter. The biotechnology company earned $6.26 million during the quarter. View 22nd Century Group's Earnings History.
When is 22nd Century Group's next earnings date?
What price target have analysts set for XXII?
1 Wall Street analysts have issued 12-month price objectives for 22nd Century Group's stock. Their forecasts range from $11.50 to $11.50. On average, they anticipate 22nd Century Group's stock price to reach $11.50 in the next twelve months. This suggests a possible upside of 304.9% from the stock's current price. View Analyst Price Targets for 22nd Century Group.
What is the consensus analysts' recommendation for 22nd Century Group?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 22nd Century Group in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for 22nd Century Group.
Has 22nd Century Group been receiving favorable news coverage?
News coverage about XXII stock has trended somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. 22nd Century Group earned a daily sentiment score of 1.1 on InfoTrie's scale. They also gave media headlines about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the near term.
Are investors shorting 22nd Century Group?
22nd Century Group saw a decrease in short interest during the month of November. As of November 30th, there was short interest totalling 16,136,666 shares, a decrease of 11.1% from the November 15th total of 18,156,345 shares. Based on an average daily trading volume, of 1,405,630 shares, the days-to-cover ratio is presently 11.5 days. Currently, 14.8% of the shares of the company are sold short. View 22nd Century Group's Current Options Chain.
Who are some of 22nd Century Group's key competitors?
Some companies that are related to 22nd Century Group include 4d Pharma (DDDD), Abattis Bioceuticals (ATTBF), Abcam (ABC), ABcann Global (ABCN), ABLYNX NV/ADR (ABLX), ABZENA/PAR VTG FPD 0.002 (ABZA), Acasti Pharma (ACST), Acrux (ACR), Actinium Pharmaceuticals (ATNM), Almirall (LBTSF), Altimmune (ALT), Ampio Pharmaceuticals (AMPE), Ampliphi Biosciences (APHB), Antibe Therapeutics (ATE) and AorTech International (AOR).
Who are 22nd Century Group's key executives?
22nd Century Group's management team includes the folowing people:
- Mr. Henry Sicignano III, Pres, CEO & Director (Age 50)
- Mr. John T. Brodfuehrer, CFO & Treasurer (Age 60)
- Mr. Thomas L. James Esq., VP, Gen. Counsel & Sec. (Age 59)
- James Vail, Director of Communications
- Dr. Paul J. Rushton, VP of Plant Biotechnology (Age 55)
Who are 22nd Century Group's major shareholders?
22nd Century Group's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.40%), Vanguard Group Inc. (4.21%), Sandler Capital Management (0.92%), Courier Capital LLC (0.29%), Wells Fargo & Company MN (0.21%) and Teachers Advisors LLC (0.20%). Company insiders that own 22nd Century Group stock include Michael Robert Moynihan and Thomas L James. View Institutional Ownership Trends for 22nd Century Group.
Which major investors are selling 22nd Century Group stock?
Which major investors are buying 22nd Century Group stock?
XXII stock was purchased by a variety of institutional investors in the last quarter, including Sandler Capital Management, BlackRock Inc., Courier Capital LLC, Dimensional Fund Advisors LP, Virtu Financial LLC, Wells Fargo & Company MN and Teachers Advisors LLC. View Insider Buying and Selling for 22nd Century Group.
How do I buy shares of 22nd Century Group?
Shares of XXII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is 22nd Century Group's stock price today?
One share of XXII stock can currently be purchased for approximately $2.84.
What is 22nd Century Group's official website?
How can I contact 22nd Century Group?
22nd Century Group's mailing address is 9530 Main St, CLARENCE, NY 14031-1915, United States. The biotechnology company can be reached via phone at +1-716-2701523.
MarketBeat Community Rating for 22nd Century Group (NYSEAMERICAN XXII)
MarketBeat's community ratings are surveys of what our community members think about 22nd Century Group and other stocks. Vote "Outperform" if you believe XXII will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XXII will underperform the S&P 500 over the long term. You may vote once every thirty days.
